
Rajiv Kumar Pruthi MD
Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias
Associate Professor, Internal Medicine, Mayo Medical School
Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Fax+1 507-255-3125
Dr. Pruthi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1991 - 1995
Aurora Health CareResidency, Internal Medicine, 1989 - 1991
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceInternship, Internal Medicine, 1988 - 1989
Kasturba Medical College ManipalClass of 1987
Certifications & Licensure
NH State Medical License 2014 - Present
MI State Medical License 2013 - 2029
FL State Medical License 2014 - 2028
MT State Medical License 2014 - 2028
AZ State Medical License 2014 - 2027
GA State Medical License 2014 - 2027
ND State Medical License 2014 - 2027
American Board of Internal Medicine Hematology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2013-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2013-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2013-2017
Clinical Trials
- Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia Start of enrollment: 1999 Aug 11
- SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors Start of enrollment: 2021 Jun 28
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Pathogenic PF4/Polyanion ELISA-Negative Antibodies in HIT.Adam J Kanack, Noah P Splinter, Emily E Mauch, Leben Tefera, Morayma Reyes Gil
American Journal of Hematology. 2026-08-01 - Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study.Tammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, Lauren E Amos, Meera Chitlur
Blood Vessels, Thrombosis & Hemostasis. 2026-08-01 - Ischemic Stroke in a Case of Myeloproliferative Neoplasm and Acquired Von Willebrand Syndrome.Sukhmani Sidhu, Rajiv K Pruthi, Binav Baral
Mayo Clinic Proceedings. 2026-07-01
Lectures
- Current Status of Clinical Laboratory Testing of Plasma Cell Neoplasms: A Case-Based Approach61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Clinical and Laboratory Diagnosis of Red Blood Cell Disorders: A Case-Based Algorithmic Approach60th American Society of Hematology Annual Meeting - 11/30/2018
Press Mentions
Science Saturday: Cross-Laboratory Collaboration Accelerates Gold-Standard SRA TestingFebruary 4th, 2023
Mayo Clinic Minute: Blood Test BasicsAugust 31st, 2017
Mayo Clinic Radio: Depression Screening/Common Blood Tests/NEAT and Weight ManagementMarch 10th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:


















